Free Trial

OptimizeRx (OPRX) Competitors

OptimizeRx logo
$4.91 +0.16 (+3.37%)
(As of 12/20/2024 05:16 PM ET)

OPRX vs. TRMR, EGHT, IBEX, ACCD, SHAP, RGP, BTOC, RMNI, AHG, and HQI

Should you be buying OptimizeRx stock or one of its competitors? The main competitors of OptimizeRx include Tremor International (TRMR), 8X8 (EGHT), IBEX (IBEX), Accolade (ACCD), Spree Acquisition Corp. 1 (SHAP), Resources Connection (RGP), Armlogi (BTOC), Rimini Street (RMNI), Akso Health Group (AHG), and HireQuest (HQI). These companies are all part of the "business services" industry.

OptimizeRx vs.

Tremor International (NASDAQ:TRMR) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings, profitability and community ranking.

Tremor International has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500.

In the previous week, OptimizeRx had 8 more articles in the media than Tremor International. MarketBeat recorded 8 mentions for OptimizeRx and 0 mentions for Tremor International. OptimizeRx's average media sentiment score of 0.98 beat Tremor International's score of 0.00 indicating that OptimizeRx is being referred to more favorably in the news media.

Company Overall Sentiment
Tremor International Neutral
OptimizeRx Positive

Tremor International has a net margin of -5.72% compared to OptimizeRx's net margin of -27.41%. Tremor International's return on equity of 3.11% beat OptimizeRx's return on equity.

Company Net Margins Return on Equity Return on Assets
Tremor International-5.72% 3.11% 1.89%
OptimizeRx -27.41%-4.92%-3.41%

OptimizeRx has a consensus price target of $9.71, suggesting a potential upside of 97.85%. Given OptimizeRx's stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than Tremor International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tremor International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
OptimizeRx
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75

7.9% of Tremor International shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 8.2% of Tremor International shares are held by company insiders. Comparatively, 6.1% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

OptimizeRx received 127 more outperform votes than Tremor International when rated by MarketBeat users. Likewise, 63.60% of users gave OptimizeRx an outperform vote while only 58.14% of users gave Tremor International an outperform vote.

CompanyUnderperformOutperform
Tremor InternationalOutperform Votes
25
58.14%
Underperform Votes
18
41.86%
OptimizeRxOutperform Votes
152
63.60%
Underperform Votes
87
36.40%

Tremor International has higher revenue and earnings than OptimizeRx. Tremor International is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tremor International$343.77M2.07$22.74M-$0.14-70.07
OptimizeRx$88.18M1.03-$17.57M-$1.33-3.69

Summary

Tremor International and OptimizeRx tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPRX vs. The Competition

MetricOptimizeRxBusiness services IndustryComputer SectorNASDAQ Exchange
Market Cap$87.50M$19.94B$25.75B$9.07B
Dividend YieldN/A2.58%2.78%4.22%
P/E Ratio-3.6927.94241.6517.19
Price / Sales1.0310.803,321.73116.80
Price / CashN/A35.3435.7337.86
Price / Book0.705.908.084.78
Net Income-$17.57M$525.34M$678.74M$225.60M
7 Day Performance-1.60%-0.65%0.42%-1.23%
1 Month Performance9.35%-2.17%6.97%3.37%
1 Year Performance-65.54%18.44%23.01%16.58%

OptimizeRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPRX
OptimizeRx
4.034 of 5 stars
$4.91
+3.4%
$9.71
+97.8%
-65.0%$87.50M$88.18M-3.69100Analyst Forecast
News Coverage
TRMR
Tremor International
N/A$5.02
+1.0%
N/A+106.2%$364.54M$343.77M-73.57167
EGHT
8X8
2.1265 of 5 stars
$2.63
flat
$2.79
+5.9%
-21.2%$343.64M$719.56M-4.781,948Analyst Forecast
IBEX
IBEX
1.2644 of 5 stars
$20.20
+0.6%
$21.25
+5.2%
+8.9%$338.65M$513.68M10.6230,000Insider Trade
ACCD
Accolade
4.9011 of 5 stars
$3.57
+2.3%
$9.04
+153.3%
-67.8%$287.52M$441.03M-3.392,400Analyst Forecast
SHAP
Spree Acquisition Corp. 1
N/A$10.91
-0.2%
N/AN/A$283.07MN/A0.00N/ANews Coverage
RGP
Resources Connection
4.356 of 5 stars
$8.34
-3.1%
$13.00
+55.9%
-41.9%$279.14M$632.80M23.923,376Positive News
BTOC
Armlogi
0.5941 of 5 stars
$5.73
+3.2%
N/AN/A$238.56M$168.21M555.00N/ANews Coverage
Positive News
Gap Up
RMNI
Rimini Street
3.0768 of 5 stars
$2.59
+31.5%
$4.50
+73.7%
-21.3%$235.48M$431.50M-5.322,120Analyst Upgrade
Positive News
High Trading Volume
AHG
Akso Health Group
0.4778 of 5 stars
$1.49
+54.4%
N/A+73.2%$217.13M$2.41M0.0040Positive News
Gap Down
High Trading Volume
HQI
HireQuest
3.6624 of 5 stars
$14.74
+0.6%
$18.50
+25.5%
-11.1%$206.36M$36.28M133.1873,000News Coverage

Related Companies and Tools


This page (NASDAQ:OPRX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners